Immunome, Inc. (IMNM) NASDAQ
$15.07 0.36 (2.45%)
Market Cap: $905.02M
As of 09/13/24 10:17 AM EDT. Market open.
Immunome, Inc. (IMNM)
NASDAQ
$15.07
0.36 (2.45%)
Market Cap: $905.02M
As of 09/13/24 10:17 AM EDT. Market open.
Add to Portfolio
Immunome Inc is a biopharmaceutical company specializing in targeted oncology therapies with a focus on developing novel treatments with best-in-class or first-in-class potential. With a pipeline of clinical and preclinical assets, including AL102 for desmoid tumors, IM-1021, IM-3050, and IM-4320, the company aims to improve outcomes for patients across various ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Clay B. Siegall Ph.D.
Full Time Employees
78
CEO Compensation (Base)
$162,500
CEO Compensation (Total)
$14.87M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Clay B. Siegall Ph.D.
Full Time Employees
78
CEO Compensation (Base)
$162,500
CEO Compensation (Total)
$14.87M
URL
Address
665 Stockton Drive, PA, Exton, 19341.
PRICE CHART FOR IMMUNOME, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15
Previous Close
$14.71
Days Range
$14.95 - $15.22
52 week range
$6.65 - $30.96
Volume
48,934
Avg. Volume (30 days)
803,024
Market Cap
$905.02M
Dividend Yield
-
P/E
(2)
Shares Outstanding
60,054,400
Open
$15
Previous Close
$14.71
Days Range
$14.95 - $15.22
52 week range
$6.65 - $30.96
Volume
48,934
Avg. Volume (30 days)
803,024
Market Cap
$905.02M
Dividend Yield
-
P/E
(2)
Shares Outstanding
60,054,400
FINANCIAL STATEMENTS FOR IMMUNOME, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR IMMUNOME, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| BIENAIME JEAN JACQUES | Director | Aug 16, 2024 | Buy | $13.94 | 7,000 | 97,608 | 16,615 | Aug 19, 2024, 09:07 PM |
| Higgins Jack | Chief Scientific Officer | Aug 15, 2024 | Option Exercise | $1.35 | 19,524 | 26,357 | 19,524 | Aug 19, 2024, 09:05 PM |
| Higgins Jack | Chief Scientific Officer | Aug 15, 2024 | Sale | $13.93 | 3,524 | 49,072 | 16,000 | Aug 19, 2024, 09:05 PM |
| BIENAIME JEAN JACQUES | Director | May 21, 2024 | Buy | $13.57 | 2,000 | 27,140 | 9,615 | May 22, 2024, 04:49 PM |
| SIEGALL CLAY B | President and CEO | May 21, 2024 | Buy | $13.78 | 20,434 | 281,548 | 419,636 | May 21, 2024, 04:13 PM |
| SIEGALL CLAY B | President and CEO | May 20, 2024 | Buy | $13.91 | 79,566 | 1,106,524 | 399,202 | May 21, 2024, 04:13 PM |
| SIEGALL CLAY B | President and CEO | Oct 02, 2023 | Buy | $5.91 | 169,204 | 999,996 | 319,636 | Oct 04, 2023, 05:35 PM |
| Turner Bruce | Chief Strategy Officer | Oct 02, 2023 | Buy | $5.91 | 42,300 | 249,993 | 42,300 | Oct 04, 2023, 05:32 PM |
| RAPP MICHAEL | Director | Oct 02, 2023 | Option Exercise | $5.91 | 253,806 | 1,499,993 | 1,071,172 | Oct 03, 2023, 05:50 PM |
| WAGENHEIM PHILIP | Director | Jan 15, 2023 | Option Exercise | $4.00 | 8,750 | 35,000 | 406,147 | Jan 17, 2023, 06:30 AM |
| LAMATTINA JOHN L | Director | Jan 15, 2023 | Option Exercise | $4.00 | 15,125 | 60,500 | 66,953 | Jan 17, 2023, 06:29 AM |
| Lefenfeld Michael | Director | Jan 15, 2023 | Option Exercise | $4.00 | 13,875 | 55,500 | 40,747 | Jan 17, 2023, 06:28 AM |
| RAPP MICHAEL | Director | Jan 15, 2023 | Option Exercise | $4.00 | 17,500 | 70,000 | 817,366 | Jan 17, 2023, 06:26 AM |
| RAPP MICHAEL | Director | Sep 13, 2021 | Buy | $19.96 | 25,962 | 518,201 | 208,742 | Sep 14, 2021, 07:28 AM |
| RAPP MICHAEL | Director | Sep 10, 2021 | Buy | $17.85 | 15,500 | 276,675 | 182,780 | Sep 13, 2021, 07:52 AM |
| RAPP MICHAEL | Director | Sep 09, 2021 | Buy | $18.19 | 30,450 | 553,774 | 167,280 | Sep 13, 2021, 07:52 AM |
| BARON RICHARD A | Director | Aug 18, 2021 | Option Exercise | $11.38 | 2,343 | 26,663 | 2,343 | Aug 20, 2021, 06:25 PM |
| Lefenfeld Michael | Director | May 26, 2021 | Buy | $19.03 | 1,335 | 25,405 | 26,872 | May 26, 2021, 09:32 PM |
| Lefenfeld Michael | Director | May 25, 2021 | Buy | $18.44 | 2,715 | 50,065 | 25,537 | May 26, 2021, 09:32 PM |
| Lefenfeld Michael | Director | May 24, 2021 | Buy | $17.80 | 600 | 10,680 | 22,822 | May 26, 2021, 09:32 PM |
| RAPP MICHAEL | Director | May 26, 2021 | Buy | $18.94 | 2,300 | 43,562 | 136,830 | May 26, 2021, 09:31 PM |
| RAPP MICHAEL | Director | May 25, 2021 | Buy | $18.32 | 19,303 | 353,631 | 134,530 | May 26, 2021, 09:31 PM |
| RAPP MICHAEL | Director | May 24, 2021 | Buy | $18.38 | 31,895 | 586,230 | 115,227 | May 26, 2021, 09:31 PM |
| RAPP MICHAEL | Director | Oct 06, 2020 | Buy | $12.00 | 83,332 | 999,984 | 638,886 | Oct 08, 2020, 06:16 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| BIENAIME JEAN JACQUES | Director | 08/16/2024 | 97,608 |
| Higgins Jack | Chief Scientific Officer | 08/15/2024 | 26,357 |
| Higgins Jack | Chief Scientific Officer | 08/15/2024 | 49,072 |
| BIENAIME JEAN JACQUES | Director | 05/21/2024 | 27,140 |
| SIEGALL CLAY B | President and CEO | 05/21/2024 | 281,548 |
| SIEGALL CLAY B | President and CEO | 05/20/2024 | 1,106,524 |
| SIEGALL CLAY B | President and CEO | 10/02/2023 | 999,996 |
| Turner Bruce | Chief Strategy Officer | 10/02/2023 | 249,993 |
| RAPP MICHAEL | Director | 10/02/2023 | 1,499,993 |
| WAGENHEIM PHILIP | Director | 01/15/2023 | 35,000 |
| LAMATTINA JOHN L | Director | 01/15/2023 | 60,500 |
| Lefenfeld Michael | Director | 01/15/2023 | 55,500 |
| RAPP MICHAEL | Director | 01/15/2023 | 70,000 |
| RAPP MICHAEL | Director | 09/13/2021 | 518,201 |
| RAPP MICHAEL | Director | 09/10/2021 | 276,675 |
| RAPP MICHAEL | Director | 09/09/2021 | 553,774 |
| BARON RICHARD A | Director | 08/18/2021 | 26,663 |
| Lefenfeld Michael | Director | 05/26/2021 | 25,405 |
| Lefenfeld Michael | Director | 05/25/2021 | 50,065 |
| Lefenfeld Michael | Director | 05/24/2021 | 10,680 |
| RAPP MICHAEL | Director | 05/26/2021 | 43,562 |
| RAPP MICHAEL | Director | 05/25/2021 | 353,631 |
| RAPP MICHAEL | Director | 05/24/2021 | 586,230 |
| RAPP MICHAEL | Director | 10/06/2020 | 999,984 |
Load More Insider Transactions
FUNDS WITH A POSITION IN IMMUNOME, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 3,758,864 | 0.00103% | 353.41% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,062,898 | 0.00113% | 145.77% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 594,000 | 0.07% | Exited | Event Driven, Value |
| BALYASNY ASSET MANAGEMENT L.P. | 375,242 | 0.00795% | 142.89% | Event Driven |
| ALPINE GLOBAL MANAGEMENT, LLC | 51,178 | 0.11% | -82.02% | Event Driven |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 220,000 | 0.00493% | New | Other |
| HHLR ADVISORS, LTD. | 107,626 | 0.03% | New | Other |
| RENAISSANCE TECHNOLOGIES LLC | 93,300 | 0.00191% | 104.97% | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 23,031 | 0.00989% | Exited | Other |
| AQR CAPITAL MANAGEMENT LLC | 16,064 | 0.0003% | 34.6% | Other |
BUYBACK ANNOUNCEMENT(S) FOR IMMUNOME, INC.
LOADING...